More Americans Smell Fear—not Roses—When They Retire
The shine is coming off of Americans’ expectations for their Golden Years.
Two-thirds of Americans anticipate being stressed about their finances in retirement, and nearly 60 percent don’t think they’ll have enough money, according to a new report by Merrill Edge.
The report found that younger generations—Gen Xers and Millennial--are the most likely to expect to feel stress in retirement. Nearly half of those who aren’t retired expect to work in retirement, and 41 percent said they’ll rely on the government for financial help in retirement.
It may not be as bad as they expect. The survey also looked at how current retirees were doing, and it found a brighter picture. About 75 percent of current retirees believe they’ll have enough money to last through retirement, while just 57 percent of pre-retirees feel the same.
Related: 5 Things No One Ever Tells You About Retirement
One promising finding in the report: Americans are putting a higher priority on saving for the future, perhaps because of their anxiety about running out of money. More than 60 percent of those surveyed said they would prioritize saving for the future, versus less than half of those asked the same question last year.
“In comparison to a year ago, we’re seeing a significant jump in positive investment behaviors and intent,” Aron Levine, head of Bank of America Preferred Banking and Merrill Edge said in a statement. “It’s encouraging to see Americans prioritizing the future along with the present and turning financial concerns into positive investment decisions.”
Chart of the Day: Boosting Corporate Tax Revenues
The leading candidates for the Democratic presidential nomination have all proposed increasing taxes on corporations, including raising income tax rates to levels ranging from 25% to 35%, up from the current 21% imposed by the Republican tax cuts in 2017. With Bernie Sanders leading the way at $3.9 trillion, here’s how much revenue the higher proposed corporate taxes, along with additional proposed surtaxes and reduced tax breaks, would generate over a decade, according to calculations by the right-leaning Tax Foundation, highlighted Wednesday by Bloomberg News.
Chart of the Day: Discretionary Spending Droops
The federal government’s total non-defense discretionary spending – which covers everything from education and national parks to veterans’ medical care and low-income housing assistance – equals 3.2% of GDP in 2020, near historic lows going back to 1962, according to an analysis this week from the Center on Budget and Policy Priorities.
Chart of the Week: Trump Adds $4.7 Trillion in Debt
The Committee for a Responsible Federal Budget estimated this week that President Trump has now signed legislation that will add a total of $4.7 trillion to the national debt between 2017 and 2029. Tax cuts and spending increases account for similar portions of the projected increase, though if the individual tax cuts in the 2017 Republican overhaul are extended beyond their current expiration date at the end of 2025, they would add another $1 trillion in debt through 2029.
Chart of the Day: The Long Decline in Interest Rates
Are interest rates destined to move higher, increasing the cost of private and public debt? While many experts believe that higher rates are all but inevitable, historian Paul Schmelzing argues that today’s low-interest environment is consistent with a long-term trend stretching back 600 years.
The chart “shows a clear historical downtrend, with rates falling about 1% every 60 years to near zero today,” says Bloomberg’s Aaron Brown. “Rates do tend to revert to a mean, but that mean seems to be declining.”
Chart of the Day: Drug Price Plans Compared
Lawmakers are considering three separate bills that are intended to reduce the cost of prescription drugs. Here’s an overview of the proposals, from a series of charts produced by the Kaiser Family Foundation this week. An interesting detail highlighted in another chart: 88% of voters – including 92% of Democrats and 85% of Republicans – want to give the government the power to negotiate prices with drug companies.
